Ashwagandha and Recovery: Reviewing the Evidence

Ashwagandha (Withania somnifera) occupies an unusual position in the supplement world: it has more controlled human research behind it than most herbs taken for stress, yet that research is also routinely overstated, and its safety profile is less benign than the marketing implies. The honest version sits between “ancient miracle” and “useless” — a less satisfying story than either extreme, but closer to the evidence.

Researchers in a laboratory examining samples during a clinical study

What the research actually supports

The strongest signal is for stress, anxiety, and cortisol. A 2025 systematic review and meta-analysis in BJPsych Open pooled 15 trials and 873 adults and found ashwagandha outperformed placebo across the board: at eight weeks, perceived stress fell by a mean of about 4.9 points on the Perceived Stress Scale, anxiety by about 3.5 points on the Hamilton Anxiety Rating Scale, and serum cortisol by roughly 2.4 units — all statistically significant.

Ashwagandha has genuine, replicated trial data for reducing perceived stress, anxiety, and cortisol. But the trials are short (mostly 8 weeks), modest in size, and use varied extracts and doses — so treat the averages as real but provisional.

The caveats matter. Most trials run 30–90 days, enroll relatively few people, sometimes have industry funding, and use different standardized extracts (KSM-66 root extract being the most studied) at doses commonly in the 300–600 mg/day range. That heterogeneity makes results harder to generalize to whatever product is on a store shelf.

An older adult jogging along a forest trail as part of an active recovery routine

Where it fits for recovery

The link to physical recovery is indirect, not direct:

Claim	Evidence
Lower perceived stress / cortisol	Replicated across multiple RCTs
Better subjective sleep quality	Supported by several smaller trials
Strength / muscle / performance	Thinner, less consistent — treat with caution
Faster tissue repair after training	Not established

If ashwagandha genuinely helps some people manage stress or sleep, that could support recovery, since both are foundational to it. But group averages hide non-responders, and claims of meaningful strength or muscle benefits run ahead of the data.

Gloved hands handling test tubes with blood samples in a clinical lab setting

Safety: better than its reputation, but not benign

Ashwagandha is generally well tolerated in trials, with mostly mild adverse events. The real concern is liver injury. NIH’s LiverTox database (maintained by the NIDDK) classifies ashwagandha as a likely cause of clinically apparent liver injury, with cases first reported in 2017 and accumulating since. Injury typically presents with a cholestatic or mixed pattern, jaundice, and itching, and usually resolves within one to four months of stopping. It is rare — but rare is not never: documented cases include emergency liver transplantation and deaths from acute-on-chronic liver failure. LiverTox advises avoiding it in people with cirrhosis or advanced chronic liver disease. It may also be inappropriate during pregnancy or with some thyroid conditions.

The takeaway

Ashwagandha is one of the better-evidenced adaptogens for stress, anxiety, and cortisol, with a softer, more indirect case for sleep and recovery and essentially no support for direct performance gains. It is neither the breakthrough its marketing implies nor a placebo to dismiss. If you try it, use a well-characterized extract, keep expectations realistic, and take the liver-injury signal seriously — especially if you have any liver condition.